Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Gepotidacin in Hepatic Impairment
NCT03562117Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gepotidacin in bacterial infection (5 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time Zero Extrapolated to Infinity and Maximum Observed Concentration. Started Jun 2018; status: completed.
02
Drugs
gepotidacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03562117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562117.